CDK 4/6 Inhibitors are Potent Radiosensitizers in Retinoblastoma Protein Positive Meningiomas Conference

Kalapurakal, JA, Wang, Y, Ghoreishi-Haack, N et al. (2022). CDK 4/6 Inhibitors are Potent Radiosensitizers in Retinoblastoma Protein Positive Meningiomas . INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 114(3), S63-S64.

cited authors

  • Kalapurakal, JA; Wang, Y; Ghoreishi-Haack, N; Wang, W; Wang, X; Xi, G; Burdett, K; Zhang, H; Gopalakrishnan, M; Mehta, MP; James, C; Horbinski, CM

authors

date/time interval

  • October 23, 2022 -

publication date

  • November 1, 2022

published in

keywords

  • Life Sciences & Biomedicine
  • Oncology
  • Radiology, Nuclear Medicine & Medical Imaging
  • Science & Technology

Location

  • ELECTR NETWORK

Conference

  • Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO)

publisher

  • ELSEVIER SCIENCE INC

start page

  • S63

end page

  • S64

volume

  • 114

issue

  • 3